收费全文 | 4017篇 |
免费 | 490篇 |
国内免费 | 139篇 |
耳鼻咽喉 | 10篇 |
儿科学 | 29篇 |
妇产科学 | 36篇 |
基础医学 | 1538篇 |
口腔科学 | 123篇 |
临床医学 | 187篇 |
内科学 | 523篇 |
皮肤病学 | 66篇 |
神经病学 | 248篇 |
特种医学 | 68篇 |
外国民族医学 | 1篇 |
外科学 | 257篇 |
综合类 | 449篇 |
预防医学 | 100篇 |
眼科学 | 39篇 |
药学 | 543篇 |
中国医学 | 102篇 |
肿瘤学 | 327篇 |
2024年 | 6篇 |
2023年 | 83篇 |
2022年 | 114篇 |
2021年 | 190篇 |
2020年 | 150篇 |
2019年 | 156篇 |
2018年 | 136篇 |
2017年 | 138篇 |
2016年 | 154篇 |
2015年 | 188篇 |
2014年 | 210篇 |
2013年 | 336篇 |
2012年 | 171篇 |
2011年 | 163篇 |
2010年 | 127篇 |
2009年 | 146篇 |
2008年 | 164篇 |
2007年 | 163篇 |
2006年 | 149篇 |
2005年 | 142篇 |
2004年 | 137篇 |
2003年 | 96篇 |
2002年 | 130篇 |
2001年 | 91篇 |
2000年 | 84篇 |
1999年 | 90篇 |
1998年 | 67篇 |
1997年 | 64篇 |
1996年 | 76篇 |
1995年 | 75篇 |
1994年 | 57篇 |
1993年 | 56篇 |
1992年 | 73篇 |
1991年 | 50篇 |
1990年 | 51篇 |
1989年 | 50篇 |
1988年 | 32篇 |
1987年 | 39篇 |
1986年 | 25篇 |
1985年 | 52篇 |
1984年 | 38篇 |
1983年 | 28篇 |
1982年 | 28篇 |
1981年 | 13篇 |
1980年 | 16篇 |
1979年 | 13篇 |
1978年 | 8篇 |
1977年 | 6篇 |
1976年 | 10篇 |
1975年 | 3篇 |
Background
Glutamine addiction is a hallmark of clear cell renal cell carcinoma (ccRCC); yet whether glutamine metabolism impacts local immune surveillance is unclear. This knowledge may yield novel immunotherapeutic opportunities.Objective
To seek a potential therapeutic target in glutamine-addicted ccRCC.Design, setting, and participants
Tumors from ccRCC patients from a Shanghai cohort and ccRCC tumor data from The Cancer Genome Atlas (TCGA) cohort were analyzed. In vivo and in vitro studies were conducted with fresh human ccRCC tumors and murine tumor cells.Outcome measurements and statistical analysis
Immune cell numbers and functions were analyzed by flow cytometry. Glutamine and cytokine concentrations were determined. Survival was compared between different subpopulations of patients using Kaplan-Meier and Cox regression analyses.Results and limitations
We found that in ccRCC, high interleukin (IL)-23 expression was significantly associated with poor survival in both TCGA (overall survival [OS] hazard ratio [HR] = 2.04, cancer-specific survival [CSS] HR = 2.95; all p < 0.001) and Shanghai (OS HR = 2.07, CSS HR = 3.92; all p < 0.001) cohorts. IL-23 blockade prolongs the survival of tumor-bearing mice, promotes T-cell cytotoxicity in in vitro cultures of human ccRCC tumors, and augments the therapeutic benefits of anti-PD-1 antibodies. Mechanistically, glutamine consumption by ccRCC tumor cells results in the local deprivation of extracellular glutamine, which induces IL-23 secretion by tumor-infiltrating macrophages via the activation of hypoxia-inducible factor 1α (HIF1α). IL-23 activates regulatory T-cell proliferation and promotes IL-10 and transforming growth factor β expression, thereby suppressing tumor cell killing by cytotoxic lymphocytes. The positive correlations between glutamine metabolism, IL-23 levels, and Treg responses are confirmed in both TCGA cohort and tumors from Shanghai ccRCC patients. Study limitations include the unclear impacts of glutamine deprivation and IL-23 on other immune cells.Conclusions
Macrophage-secreted IL-23 enhanced Treg functions in glutamine-addicted tumors; thus, IL-23 is a promising target for immunotherapy in ccRCC.Patient summary
In this study, we analyzed the immune components in glutamine-addicted clear cell renal cell carcinoma (ccRCC) tumors from two patient cohorts and conducted both in vitro and in vivo studies. We found that ccRCC tumor cell-intrinsic glutamine metabolism orchestrates immune evasion via interleukin (IL)-23, and IL-23–high patients had significantly poorer survival than IL-23–low patients. IL-23 should thus be considered a therapeutic target in ccRCC, either alone or in combination with immune checkpoint inhibitors. 相似文献Methods: The level of CXCL10 and IL-6 in spleen and serum was determined by RT-PCR and ELISA on day 14 after cryo-thermal therapy. Splenic dendritic cells (DCs) and macrophages were isolated from cryo-thermal-treated mice on day 5 and 14, and the level of CXCL10 and IL-6 in macrophages and DCs was determined by ELISA. The transwell migration assay was performed to study immune cell migration. In vivo neutralization of CXCL10 or IL-6 was performed to investigate the phenotypic changes of immune cells.
Results: Cryo-thermal therapy induced M1 macrophage polarization with up-regulation of CXCL10 and IL-6 expression in spleen. CXCL10 and IL-6 promoted DCs migration and maturation, and subsequently promoted CD4+ T cell migration and differentiation into Th1 and CD4+ CTL, moreover, reduced myeloid-derived suppressor cells (MDSCs) accumulation.
Conclusions: Cryo-thermal-induced CXCL10 and IL-6 created acute inflammatory environment to initiate a systemically cascading innate and adaptive anti-tumor immunity, which was more permissive for tumor eradication. 相似文献